186 related articles for article (PubMed ID: 34529241)
1. Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.
Kamiya S; Satake H; Hayashi Y; Ishigaki S; Ito R; Kawamura M; Taoka T; Iwano S; Naganawa S
Breast Cancer; 2022 Jan; 29(1):164-173. PubMed ID: 34529241
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Lee YJ; Youn IK; Kim SH; Kang BJ; Park WC; Lee A
Magn Reson Imaging; 2020 Feb; 66():36-41. PubMed ID: 31785544
[TBL] [Abstract][Full Text] [Related]
3. Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer.
Wang H; Zhan W; Chen W; Li Y; Chen X; Shen K
Breast; 2020 Feb; 49():33-40. PubMed ID: 31677531
[TBL] [Abstract][Full Text] [Related]
4. Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
Harada TL; Uematsu T; Nakashima K; Sugino T; Nishimura S; Takahashi K; Hayashi T; Tadokoro Y; Watanabe J; Nakamoto S; Ito T
Eur Radiol; 2020 Jun; 30(6):3363-3370. PubMed ID: 32062698
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.
Kim JH; Ko ES; Lim Y; Lee KS; Han BK; Ko EY; Hahn SY; Nam SJ
Radiology; 2017 Mar; 282(3):665-675. PubMed ID: 27700229
[TBL] [Abstract][Full Text] [Related]
6. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
Acta Radiol; 2016 Jul; 57(7):802-8. PubMed ID: 26516288
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
Bae MS; Shin SU; Ryu HS; Han W; Im SA; Park IA; Noh DY; Moon WK
Radiology; 2016 Nov; 281(2):392-400. PubMed ID: 27195438
[TBL] [Abstract][Full Text] [Related]
8. Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer.
Choi BB; Lee JS; Kim KH
Oncol Res Treat; 2018; 41(11):706-711. PubMed ID: 30321870
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.
Song SE; Woo OH; Cho Y; Cho KR; Park KH; Kim JW
Acad Radiol; 2023 Sep; 30 Suppl 2():S25-S37. PubMed ID: 37331865
[TBL] [Abstract][Full Text] [Related]
11. Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
AJR Am J Roentgenol; 2017 Mar; 208(3):687-694. PubMed ID: 28004976
[TBL] [Abstract][Full Text] [Related]
12. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
[TBL] [Abstract][Full Text] [Related]
13. Identification of triple-negative breast cancer and androgen receptor expression based on histogram and texture analysis of dynamic contrast-enhanced MRI.
Xu WJ; Zheng BJ; Lu J; Liu SY; Li HL
BMC Med Imaging; 2023 Jun; 23(1):70. PubMed ID: 37264313
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
15. Kinetic volume analysis on dynamic contrast-enhanced MRI of triple-negative breast cancer: associations with survival outcomes.
Hayashi Y; Satake H; Ishigaki S; Ito R; Kawamura M; Kawai H; Iwano S; Naganawa S
Br J Radiol; 2020 Feb; 93(1106):20190712. PubMed ID: 31821036
[TBL] [Abstract][Full Text] [Related]
16. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Xie T; Gong J; Zhao Q; Wu C; Wu S; Peng W; Gu Y
BMC Med Imaging; 2024 Jun; 24(1):136. PubMed ID: 38844842
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological Findings.
Ko ES; Kim JH; Lim Y; Han BK; Cho EY; Nam SJ
Medicine (Baltimore); 2016 Jan; 95(3):e2453. PubMed ID: 26817878
[TBL] [Abstract][Full Text] [Related]
19. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
20. Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study.
Yamaguchi A; Honda M; Ishiguro H; Kataoka M; Kataoka TR; Shimizu H; Torii M; Mori Y; Kawaguchi-Sakita N; Ueno K; Kawashima M; Takada M; Suzuki E; Nakamoto Y; Kawaguchi K; Toi M
Sci Rep; 2021 May; 11(1):10112. PubMed ID: 33980938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]